The Underground Peptide Market Is Getting Ready to Go Mainstream
Summary
Bloomberg reporters investigate the booming, largely unregulated market for injectable peptides, which promise weight loss and aesthetic benefits. The episode explores how GLP-1s served as a gateway to this underground trade, where users buy unapproved substances online. With HHS Secretary Robert F. Kennedy Jr. advocating for legalization, the discussion covers potential regulatory shifts, the rise of compounding pharmacies, and the safety risks of untested drugs.
Topics discussed
Sponsors: Hartford, IBM, and Chase Sapphire Reserve
Introduction to the peptide craze and underground market
Origin story: From bodybuilding to mainstream via GLP-1s
Case study: How a therapist started using peptides
The black market: Research chemicals and safety risks
Sponsors: Public.com and Bloomberg Daybreak
Sponsor: Drilled podcast on carbon markets
RFK Jr.'s influence and potential FDA regulatory changes
Winners and losers: Telehealth, compounding, and Big Pharma
Patient safety: Harm reduction vs. unknown long-term risks
Cultural shift: Distrust of traditional healthcare systems
Outro and sponsors: Bloomberg Summit and Drilled
Listen ad-free on Castria